Literature DB >> 30001857

Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?

Stefanie Desmet1, Jan Verhaegen2, Marc Van Ranst2, Willy Peetermans3, Katrien Lagrou2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30001857     DOI： 10.1016/S1473-3099(18)30346-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  10 in total

1.  Response to McGirr et al.'s Comment on "Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada".

Authors:  Michele R Wilson; Matt Wasserman; Taj Jadavji; Maarten Postma; Marie-Claude Breton; Francois Peloquin; Stephanie R Earnshaw; Cheryl McDade; Heather L Sings; Raymond Farkouh
Journal:  Infect Dis Ther       Date:  2018-11-08

2.  Re-Analysis of Modeling a Switch from a 13-Valent to 10-Valent Pneumococcal Conjugate Vaccine in Canada: Leveraging Real-World Experience from Belgium.

Authors:  Matt D Wasserman; Heather L Sings; Michele R Wilson; Maarten J Postma; Marie-Claude Breton; Cheryl McDade; Raymond A Farkouh
Journal:  Infect Dis Ther       Date:  2018-11-20

3.  Comment on Gomez et. al. "Response to article by Wasserman et. al. (2018) 'Modelling the sustained use of the 13-valent pneumococcal conjugate vaccine compared to switching to the 10-valent vaccine in Mexico'".

Authors:  Matt Wasserman; Maria Gabriela Palacios; Ana Gabriela Grajales; Michele Wilson; Cheryl McDade; Raymond Farkouh
Journal:  Hum Vaccin Immunother       Date:  2019-01-18       Impact factor: 3.452

4.  Burden of invasive pneumococcal disease in children in Casablanca, Morocco four years after the introduction of pneumococcal vaccination.

Authors:  Amar Chikhaoui; Néhémie Nzoyikorera; Idrissa Diawara; Zineb Jouhadi; Khalid Zerouali
Journal:  Pan Afr Med J       Date:  2022-01-03

5.  Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis.

Authors:  Sarah Pugh; Matt Wasserman; Margaret Moffatt; Susana Marques; Juan Manuel Reyes; Victor A Prieto; Davy Reijnders; Mark H Rozenbaum; Juha Laine; Heidi Åhman; Raymond Farkouh
Journal:  Infect Dis Ther       Date:  2020-02-24

Review 6.  Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia.

Authors:  Auliya A Suwantika; Neily Zakiyah; Arif S W Kusuma; Rizky Abdulah; Maarten J Postma
Journal:  Vaccines (Basel)       Date:  2020-05-18

7.  Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy.

Authors:  Filippo Ansaldi; Sarah Pugh; Daniela Amicizia; Roberto Di Virgilio; Cecilia Trucchi; Andrea Orsi; Alessandro Zollo; Giancarlo Icardi
Journal:  Pathogens       Date:  2020-01-22

8.  Invasive Pneumococcal Disease in Tuscany Region, Italy, 2016-2017: Integrating Multiple Data Sources to Investigate Underreporting.

Authors:  Filippo Quattrone; Gabriele Donzelli; Sara D'Arienzo; Marco Fornili; Francesco Innocenti; Silvia Forni; Laura Baglietto; Lara Tavoschi; Pier Luigi Lopalco
Journal:  Int J Environ Res Public Health       Date:  2020-10-19       Impact factor: 3.390

9.  Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea.

Authors:  Hye-Young Kim; Seong-Beom Park; Eun-Sil Kang; Sang-Min Lee; Hyun-Jin Kim; Matt Wasserman
Journal:  Hum Vaccin Immunother       Date:  2020-08-12       Impact factor: 3.452

10.  Genomic surveillance of invasive Streptococcus pneumoniae isolates in the period pre-PCV10 and post-PCV10 introduction in Brazil.

Authors:  Samanta C G Almeida; Stephanie W Lo; Paulina A Hawkins; Rebecca A Gladstone; Ana Paula Cassiolato; Keith P Klugman; Robert F Breiman; Stephen D Bentley; Lesley McGee; Maria-Cristina de C Brandileone
Journal:  Microb Genom       Date:  2021-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.